261 related articles for article (PubMed ID: 28258538)
1. Trends in the Prescription and Long-Term Utilization of Antidementia Drugs Among Patients with Alzheimer's Disease in Spain: A Cohort Study Using the Registry of Dementias of Girona.
Calvó-Perxas L; Turró-Garriga O; Vilalta-Franch J; Lozano-Gallego M; de Eugenio R; Márquez F; Carmona O; Gich J; Manzano A; Viñas M; Roig AM; Garre-Olmo J;
Drugs Aging; 2017 Apr; 34(4):303-310. PubMed ID: 28258538
[TBL] [Abstract][Full Text] [Related]
2. Use of antidementia drugs in frontotemporal lobar degeneration.
López-Pousa S; Calvó-Perxas L; Lejarreta S; Cullell M; Meléndez R; Hernández E; Bisbe J; Perkal H; Manzano A; Roig AM; Turró-Garriga O; Vilalta-Franch J; Garre-Olmo J;
Am J Alzheimers Dis Other Demen; 2012 Jun; 27(4):260-6. PubMed ID: 22605780
[TBL] [Abstract][Full Text] [Related]
3. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.
Lampela P; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
J Alzheimers Dis; 2020; 73(3):1243-1251. PubMed ID: 31929157
[TBL] [Abstract][Full Text] [Related]
4. Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication.
Huisa BN; Thomas RG; Jin S; Oltersdorf T; Taylor C; Feldman HH
J Alzheimers Dis; 2019; 67(2):707-713. PubMed ID: 30636733
[TBL] [Abstract][Full Text] [Related]
5. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
[TBL] [Abstract][Full Text] [Related]
6. Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study.
Koller D; Hua T; Bynum JP
J Am Geriatr Soc; 2016 Aug; 64(8):1540-8. PubMed ID: 27341454
[TBL] [Abstract][Full Text] [Related]
7. Memantine in Alzheimer's disease: experience in an Alzheimer's disease assessment unit.
Sinforiani E; Pasotti C; Chiapella L; Malinverni P; Zucchella C
Aging Clin Exp Res; 2012 Apr; 24(2):193-6. PubMed ID: 22842837
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.
Hartmann S; Möbius HJ
Int Clin Psychopharmacol; 2003 Mar; 18(2):81-5. PubMed ID: 12598818
[TBL] [Abstract][Full Text] [Related]
9. Association between antidementia medication use and mortality in people diagnosed with dementia with Lewy bodies in the UK: A retrospective cohort study.
Chen S; Price AC; Cardinal RN; Moylett S; Kershenbaum AD; Fitzgerald J; Mueller C; Stewart R; O'Brien JT
PLoS Med; 2022 Dec; 19(12):e1004124. PubMed ID: 36472984
[TBL] [Abstract][Full Text] [Related]
10. Association of Antidementia Therapies With Time to Skilled Nursing Facility Admission and Cardiovascular Events Among Elderly Adults With Alzheimer Disease.
San-Juan-Rodriguez A; Zhang Y; He M; Hernandez I
JAMA Netw Open; 2019 Mar; 2(3):e190213. PubMed ID: 30821828
[TBL] [Abstract][Full Text] [Related]
11. A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease.
Castagna A; Fabbo A; Manzo C; Lacava R; Ruberto C; Ruotolo G
J Alzheimers Dis; 2021; 79(4):1509-1515. PubMed ID: 33459645
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].
Sicras-Mainar A; Vergara J; Leon-Colombo T; Febrer L; Rejas-Gutierrez J
Rev Neurol; 2006 Oct 16-31; 43(8):449-53. PubMed ID: 17033976
[TBL] [Abstract][Full Text] [Related]
13. Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries.
Thorpe CT; Fowler NR; Harrigan K; Zhao X; Kang Y; Hanlon JT; Gellad WF; Schleiden LJ; Thorpe JM
J Am Geriatr Soc; 2016 Sep; 64(9):1806-14. PubMed ID: 27549029
[TBL] [Abstract][Full Text] [Related]
14. Anti-dementia drugs: a descriptive study of the prescription pattern in Italy.
Ippoliti I; Ancidoni A; Da Cas R; Pierantozzi A; Vanacore N; Trotta F
Neurol Sci; 2023 May; 44(5):1587-1595. PubMed ID: 36595207
[TBL] [Abstract][Full Text] [Related]
15. Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study.
Martinez C; Jones RW; Rietbrock S
BMJ Open; 2013 Jan; 3(1):. PubMed ID: 23299113
[TBL] [Abstract][Full Text] [Related]
16. Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients.
Babiloni C; Del Percio C; Bordet R; Bourriez JL; Bentivoglio M; Payoux P; Derambure P; Dix S; Infarinato F; Lizio R; Triggiani AI; Richardson JC; Rossini PM
Clin Neurophysiol; 2013 May; 124(5):837-50. PubMed ID: 23098644
[TBL] [Abstract][Full Text] [Related]
17. Trends of antidementia drugs use in outpatients with Alzheimer's disease in six major cities of China: 2012-2017.
Yu L; Chen X; Yu Z
Int Clin Psychopharmacol; 2019 Nov; 34(6):312-316. PubMed ID: 31274694
[TBL] [Abstract][Full Text] [Related]
18. Psychotropic drugs in patients with Alzheimer's Disease: a longitudinal study by the Registry of Dementias of Girona (ReDeGi) in Catalonia, Spain.
Calvó-Perxas L; Turró-Garriga O; Aguirregomozcorta M; Bisbe J; Hernández E; López-Pousa S; Manzano A; Palacios M; Pericot-Nierga I; Perkal H; Ramió L; Vilalta-Franch J; Garre-Olmo J;
J Am Med Dir Assoc; 2014 Jul; 15(7):497-503. PubMed ID: 24637090
[TBL] [Abstract][Full Text] [Related]
19. Memantine and acetylcholinesterase inhibitor treatment in cases of CDR 0.5 or questionable impairment.
McClendon MJ; Hernandez S; Smyth KA; Lerner AJ
J Alzheimers Dis; 2009; 16(3):577-83. PubMed ID: 19276552
[TBL] [Abstract][Full Text] [Related]
20. An Overview of Combination Treatment with Citicoline in Dementia.
Gareri P; Veronese N; Cotroneo AM
Rev Recent Clin Trials; 2022; 17(1):4-8. PubMed ID: 34939548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
